These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 9773978

  • 21. The small heterodimer partner interacts with the liver X receptor alpha and represses its transcriptional activity.
    Brendel C, Schoonjans K, Botrugno OA, Treuter E, Auwerx J.
    Mol Endocrinol; 2002 Sep; 16(9):2065-76. PubMed ID: 12198243
    [Abstract] [Full Text] [Related]

  • 22. Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells.
    Bai Y, Giguére V.
    Mol Endocrinol; 2003 Apr; 17(4):589-99. PubMed ID: 12554772
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens.
    Hall JM, McDonnell DP.
    Endocrinology; 1999 Dec; 140(12):5566-78. PubMed ID: 10579320
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Colocalization and ligand-dependent discrete distribution of the estrogen receptor (ER)alpha and ERbeta.
    Matsuda K, Ochiai I, Nishi M, Kawata M.
    Mol Endocrinol; 2002 Oct; 16(10):2215-30. PubMed ID: 12351687
    [Abstract] [Full Text] [Related]

  • 27. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes.
    Lazennec G, Ediger TR, Petz LN, Nardulli AM, Katzenellenbogen BS.
    Mol Endocrinol; 1997 Aug; 11(9):1375-86. PubMed ID: 9259327
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Deoxyribonucleic acid response element-dependent regulation of transcription by orphan nuclear receptor estrogen receptor-related receptor gamma.
    Sanyal S, Matthews J, Bouton D, Kim HJ, Choi HS, Treuter E, Gustafsson JA.
    Mol Endocrinol; 2004 Feb; 18(2):312-25. PubMed ID: 14645497
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Thyroid hormone is an inhibitor of estrogen-induced degradation of estrogen receptor-alpha protein: estrogen-dependent proteolysis is not essential for receptor transactivation function in the pituitary.
    Alarid ET, Preisler-Mashek MT, Solodin NM.
    Endocrinology; 2003 Aug; 144(8):3469-76. PubMed ID: 12865327
    [Abstract] [Full Text] [Related]

  • 32. Subnuclear trafficking of estrogen receptor-alpha and steroid receptor coactivator-1.
    Stenoien DL, Mancini MG, Patel K, Allegretto EA, Smith CL, Mancini MA.
    Mol Endocrinol; 2000 Apr; 14(4):518-34. PubMed ID: 10770489
    [Abstract] [Full Text] [Related]

  • 33. SHP represses transcriptional activity via recruitment of histone deacetylases.
    Gobinet J, Carascossa S, Cavaillès V, Vignon F, Nicolas JC, Jalaguier S.
    Biochemistry; 2005 Apr 26; 44(16):6312-20. PubMed ID: 15835920
    [Abstract] [Full Text] [Related]

  • 34. Estrogen receptor beta acts as a dominant regulator of estrogen signaling.
    Pettersson K, Delaunay F, Gustafsson JA.
    Oncogene; 2000 Oct 12; 19(43):4970-8. PubMed ID: 11042684
    [Abstract] [Full Text] [Related]

  • 35. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members.
    Kraichely DM, Sun J, Katzenellenbogen JA, Katzenellenbogen BS.
    Endocrinology; 2000 Oct 12; 141(10):3534-45. PubMed ID: 11014206
    [Abstract] [Full Text] [Related]

  • 36. The inhibitory activity of a transdominant c-jun mutant fused to the ligand binding domain of the estrogen receptor.
    Kim S, Brown PH, Birrer MJ.
    Oncogene; 1996 Mar 07; 12(5):1043-53. PubMed ID: 8649795
    [Abstract] [Full Text] [Related]

  • 37. Function of N-terminal transactivation domain of the estrogen receptor requires a potential alpha-helical structure and is negatively regulated by the A domain.
    Métivier R, Petit FG, Valotaire Y, Pakdel F.
    Mol Endocrinol; 2000 Nov 07; 14(11):1849-71. PubMed ID: 11075817
    [Abstract] [Full Text] [Related]

  • 38. Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation.
    Oesterreich S, Zhang Q, Hopp T, Fuqua SA, Michaelis M, Zhao HH, Davie JR, Osborne CK, Lee AV.
    Mol Endocrinol; 2000 Mar 07; 14(3):369-81. PubMed ID: 10707955
    [Abstract] [Full Text] [Related]

  • 39. Estrogen receptor (ER)-mediated transcriptional regulation of the human corticotropin-releasing hormone-binding protein promoter: differential effects of ERalpha and ERbeta.
    van de Stolpe A, Slycke AJ, Reinders MO, Zomer AW, Goodenough S, Behl C, Seasholtz AF, van der Saag PT.
    Mol Endocrinol; 2004 Dec 07; 18(12):2908-23. PubMed ID: 15345745
    [Abstract] [Full Text] [Related]

  • 40. Synergistic regulation of the mouse orphan nuclear receptor SHP gene promoter by CLOCK-BMAL1 and LRH-1.
    Oiwa A, Kakizawa T, Miyamoto T, Yamashita K, Jiang W, Takeda T, Suzuki S, Hashizume K.
    Biochem Biophys Res Commun; 2007 Feb 23; 353(4):895-901. PubMed ID: 17204240
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.